The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016
Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 573s Year: 2006
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Relationship between anthropometric parameters, sleep disordered breathing and airway inflammation (AI) in obese adults affected by obstructive sleep apnea (OSA) Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Body composition in obese males with obstructive sleep apnea (OSA) Source: Eur Respir J 2004; 24: Suppl. 48, 572s Year: 2004
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
Prevalence of obstructive sleep apnea syndrome in obese children (NANOS study) Source: Annual Congress 2012 - Paediatrics and sleep apnoea/adults and upper airway stimulation Year: 2012
Hyperuricaemia in males with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Hyperuricaemia in females with obstructive sleep apnoea (OSA) Source: Eur Respir J 2003; 22: Suppl. 45, 91s Year: 2003
Differences in polysomnographic (PSG) parameters between obese and non-obese patients with obstructive sleep apnea (OSA) Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019
Obesity, obstructive sleep apnea (OSA) and asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Insulin resistance in obstructive sleep apnea patients Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004